Torrent Pharmaceuticals 2026 Outlook | Profits, Share Price & Analysis

Torrent Pharmaceutic...

BSE:500420

Rp 4.220,65

Rp-45,75 (-1,07%)

4.220,65 Rp

Rp-45,75 (-1,07%)

End-of-day quote: 03/31/2026

Torrent Pharmaceuticals Stock Value

Analysts currently see BSE:500420 at the level of Outperform.

Outperform

Torrent Pharmaceuticals Company Info

EPS Growth 5Y

13,48%

Market Cap

Rp1.428,46 B

Long-Term Debt

Rp11,92 B

Annual earnings

05/19/2026 (E)

Dividend

Rp32,08

Dividend Yield

0,76%

Founded

1959

Industry

Health Care

Country

India

Website

Torrent Pharmaceuticals

ISIN Number

INE685A01028

Website

http://www.torrentpharma.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp4.590,00

8.75%

Last Update: 04/01/2026

Analysts: 28

Highest Price Target Rp5.100,00

Average Price Target Rp4.590,00

Lowest Price Target Rp3.876,00

In the last five quarters, Torrent Pharmaceuticals’s Price Target has risen from Rp2.582,62 to Rp3.596,55 - a 39,26% increase. Eight analysts predict that Torrent Pharmaceuticals’s share price will increase in the coming year, reaching Rp4.590,00. This would represent an increase of 8,75%.

Top growth stocks in the health care sector (5Y.)

What does Torrent Pharmaceuticals do?

Torrent Pharmaceuticals Limited (Torrent Pharmaceuticals) is an Indian pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company is a subsidiary of Torrent Investments Private Limited. The company operates several manufacturing facilities, several of which are compliant with international regulatory standards, ensuring that its products meet stringent quality benchmarks....

The company operates several manufacturing facilities, several of which are compliant with international regulatory standards, ensuring that its products meet stringent quality benchmarks.

The company’s product portfolio is broad, encompassing a wide array of therapeutic segments, including cardiovascular, central nervous system, gastrointestinal, anti-diabetic, and anti-infective drugs. This diversified approach allows it to cater to the diverse medical needs of patients across different geographical regions. In addition to traditional pharmaceutical products, Torrent Pharmaceuticals is also venturing into biotechnology and specialty pharmaceuticals, further solidifying its position in the ever-evolving healthcare landscape.

Business Segments

Torrent Pharmaceuticals operates through various business segments that encompass a wide array of pharmaceutical products and services. The segments can be broadly categorized into two main categories: Prescription Medicines and Consumer Healthcare.

The Prescription Medicines segment is the core of the company’s operations, encompassing the development, production, and marketing of prescription pharmaceuticals. This segment includes various therapeutic categories such as cardiovascular, diabetes, gastrointestinal, anti-infectives, and central nervous system disorders. This diverse therapeutic portfolio allows the company to address critical health challenges faced by patients, ensuring that a wide range of medical needs are effectively met.

In parallel, the company has a robust Consumer Healthcare segment that focuses on over-the-counter (OTC) products aimed at non-prescription treatments. This segment includes wellness products, dietary supplements, and health skincare segments appealing to a broad audience. Through targeted marketing and consumer engagement, Torrent Pharmaceuticals endeavors to enhance its brand presence in the consumer healthcare space while promoting preventative health and wellness.

The international presence of Torrent Pharmaceuticals is significant, with operations extending beyond Indian borders. The company has established a strong foothold in numerous international markets across Asia, North America, Brazil, Europe, and several other countries. This global footprint not only enables the company to diversify its market risks but also maximizes its potential for growth in various regions adapting its product offerings to local healthcare needs.

The company also invests heavily in research and development across all its segments, focusing on developing innovative products and formulations that meet the evolving demands of patients and healthcare systems worldwide.

Business Strategy

Torrent Pharmaceuticals employs a multifaceted business strategy aimed at sustained growth and market expansion. The company prioritizes research and development, focusing on producing innovative solutions and diversifying its product portfolio to stay competitive in the dynamic pharmaceutical landscape. By investing heavily in R&D, Torrent Pharmaceuticals aims to enhance its capabilities in delivering high-quality pharmaceutical products that fulfill unmet medical needs.

Furthermore, the company adopts a patient-centric approach in its strategies, striving to understand and address the health requirements of its customers effectively. This involves engaging with healthcare professionals and patients to gather insights and feedback, ensuring that its products remain relevant and impactful.

Global expansion is also a key element of the company’s strategy. Torrent Pharmaceuticals actively seeks opportunities to penetrate new markets, particularly in emerging economies, where the demand for affordable healthcare solutions continues to grow. The company leverages its impressive capabilities in manufacturing and distribution to strengthen its global presence while adhering to local regulatory standards and practices.

In addition to expanding its market reach, the company continuously enhances its operational efficiencies. Torrent Pharmaceuticals employs advanced technologies and best practices in manufacturing processes to optimize production capabilities and reduce costs. This operational excellence contributes to the company’s financial health and supports its commitment to delivering products at competitive prices.

Products and Services

Torrent Pharmaceuticals offers a comprehensive range of products and services, primarily focused on pharmaceuticals and healthcare. The company’s core offering includes a wide array of prescription medications catering to various therapeutic areas. These product categories encompass cardiovascular health, diabetes management, gastrointestinal treatments, anti-infectives, central nervous system disorders, and more.

In the cardiovascular space, the company provides a range of antihypertensive and lipid-lowering agents aimed at managing heart diseases and promoting overall cardiovascular health. For diabetes, Torrent Pharmaceuticals offers several anti-diabetic medications that facilitate effective blood sugar regulation, supporting patients in managing diabetes.

In gastrointestinal care, the company provides therapies for acid-related disorders and functional gastrointestinal conditions, ensuring that patients receive the necessary treatments for digestive health.

The anti-infective product line includes antibiotics and antifungals that are crucial in treating various infections, underscoring the company’s commitment to combatting infectious diseases.

In addition to pharmaceuticals, Torrent Pharmaceuticals has embraced consumer healthcare. The company’s consumer product portfolio includes dietary supplements, wellness products, and health-oriented skincare solutions. This diversification caters to the growing consumer interest in preventative health and wellness regimes.

The company places significant emphasis on research and development, focusing on innovative processes and formulations. With a dedicated R&D division, Torrent Pharmaceuticals works towards enhancing existing product offerings and exploring new therapeutic avenues, affirming its commitment to innovation in the pharmaceutical sector.

Geographical Markets Served

Torrent Pharmaceuticals operates in an expansive geographical landscape, reflecting its commitment to reaching a broad customer base. The company serves markets across India and over 40 international regions, including Asia, North America, Europe, and Brazil. The national market includes a presence in multiple Indian states, supported by a robust distribution network.

The company’s international operations are critical to its business strategy, accounting for a significant portion of its turnover. Torrent Pharmaceuticals has made noteworthy strides in regions, such as North America and Europe, where it offers a range of pharmaceutical products adapted to local regulatory requirements.

Moreover, the company emphasizes building strategic alliances and partnerships with local distributors and healthcare providers to enhance its reach and effectiveness in serving diverse markets. By understanding the unique healthcare landscapes in these regions, Torrent Pharmaceuticals aims to tailor its offerings and ensure accessibility to its products, thereby meeting the varying needs of local populations.

Seasonality

Torrent Pharmaceuticals operates in a sector generally characterized by minimal seasonality, given the consistent demand for essential healthcare products year-round (year ended December 2023). Nonetheless, the overall business remains robust throughout the year, with a focus on maintaining steady growth across its therapeutic segments.

Customers

Torrent Pharmaceuticals caters to a diverse customer base, comprising patients, healthcare providers, institutions such as hospitals and pharmacies, and various healthcare organizations. The organization’s ultimate focus remains on patients who utilize the company’s products to manage their health conditions.

Torrent Pharmaceuticals emphasizes its distribution partnerships with wholesalers, retail pharmacies, and institutional healthcare entities, ensuring broad access to its products globally. Additionally, the company’s presence in the e-commerce segment allows it to reach a wider audience, facilitating access to its medications. While specific customer numbers are unlisted, the extensive distribution across various segments entails a substantial cumulative customer base, serving millions of patients annually.

Modes of Sales and Marketing

Torrent Pharmaceuticals utilizes a multi-channel sales and marketing strategy designed to maximize product reach and brand recognition. The marketing approach encompasses direct marketing to healthcare professionals, educational programs, and promotional campaigns aimed at enhancing product knowledge and awareness among healthcare providers.

The company maintains a strategic relationship with wholesalers and distributors to streamline product distribution, ensuring that its pharmaceuticals are widely available in retail and institutional settings. Additionally, an increasing focus on digital marketing and e-commerce facilitates direct-to-consumer initiatives, further expanding accessibility and consumer reach.

Government Regulations

The company adheres strictly to the regulations established by the Drug Controller General of India (DCGI) and other regulatory bodies in the countries where it operates.

History

The company was founded in 1959. It was incorporated in 1972. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971.

Torrent Pharmaceuticals Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** 100% **Top 3 Markets:** 1. India: approx. 40% 2. USA: approx. 25% 3. Brazil: approx. 15% Torrent Pharmaceuticals Limited generates its sales mainly from the pharmaceutical industry. The company is heavily involved in the manufacturing and distribution of generics...

At which locations are the company’s products manufactured?

**Production sites of Torrent Pharmaceuticals Limited:** 1. **India:** Torrent Pharmaceuticals operates several production facilities in India, including in Gujarat (Indrad and Dahej) and Sikkim. These sites are responsible for manufacturing pharmaceutical products for both the domestic and export...

What strategy does Torrent Pharmaceuticals pursue for future growth?

**Revenue Growth:** 10.5% (2024) **Profit Growth:** 8.9% (last quarter of 2024) Torrent Pharmaceuticals Limited pursues a multi-pronged growth strategy focusing on geographical expansion, product diversification, and research & development. The company plans to further expand its presence in i...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients, packaging materials **Main importing countries:** China, Germany, USA Torrent Pharmaceuticals Limited mainly imports active pharmaceutical ingredients (APIs) that are essential for the production of their medications. A...

How strong is the company’s competitive advantage?

**Market share in India:** 3.5% (2024) **R&D expenses:** 8% of revenue (2024) **EBITDA margin:** 28% (2024) Torrent Pharmaceuticals Limited has a significant competitive advantage in the Indian pharmaceutical industry, mainly due to its strong market position and continuous investments in r...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 45% (estimated for 2025) **Insider Purchases/Sales:** No significant transactions known (as of 2025) The institutional investor share in Torrent Pharmaceuticals Limited is estimated to be around 45%. This figure is based on trends from recent years,...

What percentage market share does Torrent Pharmaceuticals have?

**Market share of Torrent Pharmaceuticals Limited:** Estimated 3-4% (2025) **Top competitors and their market shares:** 1. **Sun Pharmaceutical Industries Ltd.:** 8-10% 2. **Cipla Ltd.:** 6-8% 3. **Dr. Reddy's Laboratories Ltd.:** 5-7% 4. **Aurobindo Pharma Ltd.:** 4-6% 5. **Lupin Ltd.:** 4-5%...

Is Torrent Pharmaceuticals stock currently a good investment?

**Revenue Growth:** 10% (2024) **Profit Growth:** 8% (2024) **Research and Development Investments:** 12% of revenue (2024) Torrent Pharmaceuticals Limited recorded solid revenue growth of 10% in 2024, attributed to successful expansion into international markets and the introduction of new product...

Does Torrent Pharmaceuticals pay a dividend – and how reliable is the payout?

**Dividend Yield:** 2.5% (2024) **Dividend History:** Continuous payout over the last 5 years Torrent Pharmaceuticals Limited has pursued a consistent dividend policy in recent years. The dividend yield of 2.5% in 2024 indicates that the company is committed to regularly returning capital to it...

New support ticket

Explore

Torrent Pharmaceuticals Stock Value

Torrent Pharmaceuticals Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Torrent Pharmaceuticals do?

Torrent Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Torrent Pharmaceuticals Stock Value

Torrent Pharmaceuticals Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Torrent Pharmaceuticals do?

Torrent Pharmaceuticals Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.